FBIO

Fortress Biotech (FBIO)

About Fortress Biotech (FBIO)

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Details

Daily high
$1.73
Daily low
$1.62
Price at open
$1.69
52 Week High
$2.89
52 Week Low
$1.32
Market cap
50.0M
Dividend yield
0.00%
Volume
116,091
Avg. volume
148,657
P/E ratio
-.59

Fortress Biotech News

Details

Daily high
$1.73
Daily low
$1.62
Price at open
$1.69
52 Week High
$2.89
52 Week Low
$1.32
Market cap
50.0M
Dividend yield
0.00%
Volume
116,091
Avg. volume
148,657
P/E ratio
-.59